在新冠疫情时代，野生脊髓灰质炎病毒1型和疫苗衍生病例带来的威胁日益增大。 - Suppr

The growing threat of wild poliovirus 1 and vaccine-derived cases in the COVID-19 era.

作者信息

Franco-Paredes Carlos, Rodriguez-Morales Alfonso J, Henao-Martínez Andrés F, Carrasco Peter, Tuells Jose

机构信息

Hospital Infantil de México Federico Gómez, Mexico City 06720, Mexico.

Grupo de Investigación Biomedicina, Faculty of Medicine, Institución Universitaria Visión de las Américas, Pereira, Colombia; Universidad Científica del Sur, Lima, Peru.

出版信息

Lancet Infect Dis. 2022 Oct;22(10):1412-1414. doi: 10.1016/S1473-3099(22)00548-5. Epub 2022 Aug 16.

DOI:10.1016/S1473-3099(22)00548-5

PMID:35985345

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9381021/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b53d/9381021/8d80ed3919ec/fx1_lrg.jpg

相似文献

The growing threat of wild poliovirus 1 and vaccine-derived cases in the COVID-19 era.在新冠疫情时代，野生脊髓灰质炎病毒1型和疫苗衍生病例带来的威胁日益增大。

Lancet Infect Dis. 2022 Oct;22(10):1412-1414. doi: 10.1016/S1473-3099(22)00548-5. Epub 2022 Aug 16.

Vaccine-derived poliovirus cases exceed wild types.疫苗衍生脊髓灰质炎病毒病例超过野生型病例。

Lancet Infect Dis. 2019 Feb;19(2):140. doi: 10.1016/S1473-3099(19)30012-X. Epub 2019 Jan 30.

Inactivated poliovirus vaccine following oral poliovirus vaccine cessation.口服脊髓灰质炎疫苗停用后接种灭活脊髓灰质炎疫苗

Wkly Epidemiol Rec. 2006 Apr 14;81(15):137-44.

Halting vaccine-derived poliovirus circulation: the novel type 2 oral vaccine might not be enough.阻止疫苗衍生脊髓灰质炎病毒的传播：新型2型口服疫苗可能还不够。

Lancet Glob Health. 2023 Jun;11(6):e811-e812. doi: 10.1016/S2214-109X(23)00161-4.

Circulating vaccine derived poliovirus and the polio eradication endgame.循环疫苗衍生脊髓灰质炎病毒与脊髓灰质炎根除的最后阶段

Pan Afr Med J. 2012;12:109. Epub 2012 Aug 20.

Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).美国的脊髓灰质炎预防：采用先接种灭活脊髓灰质炎病毒疫苗后接种口服脊髓灰质炎病毒疫苗的序贯接种程序。免疫实践咨询委员会（ACIP）的建议

MMWR Recomm Rep. 1997 Jan 24;46(RR-3):1-25.

Current issues in evaluating the efficacy of oral poliovirus vaccine and inactivated poliovirus vaccine immunization.评估口服脊髓灰质炎疫苗和灭活脊髓灰质炎疫苗免疫效果的当前问题。

Pediatr Infect Dis J. 1991 Dec;10(12):979-81. doi: 10.1097/00006454-199112000-00032.

When can we stop using oral poliovirus vaccine?我们什么时候可以停止使用口服脊髓灰质炎疫苗？

J Infect Dis. 2005 Dec 15;192(12):2033-5. doi: 10.1086/498171. Epub 2005 Nov 8.

[Possible method of eradication of poliomyelitis as an infection].[作为一种感染性疾病根除脊髓灰质炎的可能方法]

Zh Mikrobiol Epidemiol Immunobiol. 2012 May-Jun(3):107-13.

Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan.在日本开发和引进源自 Sabin 株的脊髓灰质炎灭活疫苗。

Vaccine. 2016 Apr 7;34(16):1975-85. doi: 10.1016/j.vaccine.2014.11.015. Epub 2014 Nov 21.

引用本文的文献

Advancements in Viral Genomics: Gated Recurrent Unit Modeling of SARS-CoV-2, SARS, MERS, and Ebola viruses.病毒基因组学的进展：严重急性呼吸综合征冠状病毒2（SARS-CoV-2）、严重急性呼吸综合征（SARS）、中东呼吸综合征（MERS）和埃博拉病毒的门控循环单元建模

Rev Soc Bras Med Trop. 2025 Feb 7;58:e004012024. doi: 10.1590/0037-8682-0178-2024. eCollection 2025.

Evaluating the Compatibility of Three Aluminum Salt-Adjuvanted Recombinant Protein Antigens (Trivalent NRRV) Combined with a Mock Trivalent Sabin-IPV Vaccine: Analytical and Formulation Challenges.评估三种铝盐佐剂重组蛋白抗原（三价NRRV）与模拟三价萨宾-灭活脊髓灰质炎疫苗（Mock Trivalent Sabin-IPV Vaccine）的兼容性：分析和配方挑战

Vaccines (Basel). 2024 Sep 26;12(10):1102. doi: 10.3390/vaccines12101102.

Geographic information system and information visualization capacity building: Successful polio eradication and current and future challenges in the COVID-19 era for the World Health Organization's African region.地理信息系统和信息可视化能力建设：世界卫生组织非洲区域在成功根除脊灰炎和当前及未来 COVID-19 时代面临的挑战。

PLoS One. 2024 Aug 15;19(8):e0307001. doi: 10.1371/journal.pone.0307001. eCollection 2024.

Development of a Consolidated Health Facility Masterlist Using Data From Polio Electronic Surveillance in the World Health Organization African Region.利用世界卫生组织非洲区域脊灰电子监测数据制定综合卫生设施总清单。

JMIR Public Health Surveill. 2024 Jun 21;10:e54250. doi: 10.2196/54250.

Two centuries of vaccination: historical and conceptual approach and future perspectives.两百年来的疫苗接种：历史与概念方法及未来展望。

Front Public Health. 2024 Jan 9;11:1326154. doi: 10.3389/fpubh.2023.1326154. eCollection 2023.

Is it time to switch to a formulation other than the live attenuated poliovirus vaccine to prevent poliomyelitis?是否到了改用其他减毒活疫苗而非口服脊髓灰质炎减毒活疫苗来预防脊髓灰质炎的时候了？

Front Public Health. 2024 Jan 8;11:1284337. doi: 10.3389/fpubh.2023.1284337. eCollection 2023.

The emergence of the circulating vaccine-derived poliovirus type 2 in multiple countries requires active surveillance: current scenario and counteracting strategies.多个国家出现的2型循环疫苗衍生脊髓灰质炎病毒需要进行主动监测：当前情况及应对策略。

Int J Surg. 2024 Dec 1;110(12):8167-8168. doi: 10.1097/JS9.0000000000000099.

Recent poliovirus outbreaks and vaccination: A perspective.近期脊髓灰质炎病毒疫情与疫苗接种：一种观点。

Ann Med Surg (Lond). 2022 Nov 18;84:104970. doi: 10.1016/j.amsu.2022.104970. eCollection 2022 Dec.

本文引用的文献

Global epidemiology of vaccine-derived poliovirus 2016-2021: A descriptive analysis and retrospective case-control study.2016 - 2021年疫苗衍生脊髓灰质炎病毒的全球流行病学：描述性分析与回顾性病例对照研究

EClinicalMedicine. 2022 Jun 25;50:101508. doi: 10.1016/j.eclinm.2022.101508. eCollection 2022 Aug.

No one is safe until everyone is safe-from polio too.在每个人都安全之前，没有人是安全的——包括免受小儿麻痹症侵害。

BMJ. 2022 Jun 30;377:o1625. doi: 10.1136/bmj.o1625.

Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021.新型口服脊髓灰质炎疫苗 2 型病毒在紧急使用清单下初步使用阶段的基因特征-全球，2021 年 3 月至 10 月。

MMWR Morb Mortal Wkly Rep. 2022 Jun 17;71(24):786-790. doi: 10.15585/mmwr.mm7124a2.

U.S. bound journey of migrant peoples InTransit across Dante's Inferno and Purgatory in the Americas.移民穿越但丁《神曲》中美洲地狱与炼狱的赴美之旅。

Travel Med Infect Dis. 2022 May-Jun;47:102317. doi: 10.1016/j.tmaid.2022.102317. Epub 2022 Mar 24.

Public health concerns over polio in war-torn Ukraine and nearby regions: Four lessons and a warning from the history of epidemics.

J Med Virol. 2022 Jul;94(7):2931-2932. doi: 10.1002/jmv.27723. Epub 2022 Mar 23.

Current Challenges to Achieving a Polio Free World.

Ann Acad Med Singap. 2020 Sep;49(9):704-706.

Preventing paralytic polio caused by vaccine-derived poliovirus type 2.预防2型疫苗衍生脊髓灰质炎病毒引起的麻痹性脊髓灰质炎。

Lancet Infect Dis. 2020 Jan;20(1):21-22. doi: 10.1016/S1473-3099(19)30692-9.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The growing threat of wild poliovirus 1 and vaccine-derived cases in the COVID-19 era.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献